Salute e Benessere

Bone Cement & Glue Market worth $2,248 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876 Browse in-depth TOC on "Bone Cement & Glue Market"167 - Tables 32 - Figures 188 - Pages Bone Cement & Glue Market Scope: Francein European Bone cement & glue market to witness the highest shares during the forecast period. The Europe Bone cement...
PR Newswire
01/08/2023

The Portrait Project gives clinical trial patients a platform to share their…

Headlines involving clinical research often focus on scientific breakthroughs. But behind every groundbreaking innovation are thousands of people – oftentimes critically ill people who are searching for a miracle - who were required to prove the effectiveness of the therapy. Yet, so often, little is known or understood about these people, why they enrolled in the clinical study, and how the trial affected them and their loved ones. The Portrait Project serves to share these often-overlooked…
PR Newswire
01/08/2023

Natural Refrigerant Market to Reach $2.7 Billion, Globally, by 2032 at 6.2%…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/61953 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/61953 Prime determinants of growth The global natural refrigerant market is experiencing growth due to several factors such as growing demand for frozen food and dairy products and the properties of natural refrigerants such as being non-toxic, high efficiency, environment friendly, and...
PR Newswire
01/08/2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an…

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RDResults support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug.01, 2023(GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of...
Nasdaq GlobeNewswire
01/08/2023

Peija Medical Announces First Chinese Patient Implanted with TaurusTrio™…

The clinical trial of the TaurusTrio™ TAVR system is designed to assess the safety and efficacy of the system for treating patients with native symptomatic, severe AR, who are judged by a Heart Team (including a cardiac surgeon), to be at high or greater risk for surgical aortic valve replacement. The result of this clinical trial would be included in the Company's future submission of registration application to the National Medical Products Administration (NMPA). The clinical trial of the...
PR Newswire
01/08/2023

uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent…

~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington's disease showing preservation of function compared to baseline and clinical benefits relative to natural history; both dose cohorts of AMT-130 continue to be generally well-tolerated ~ ~ Preparations underway to initiate two Phase I/II clinical trials in refractory temporal lobe epilepsy andSOD1-ALS later this year; IND for Fabry disease expected to be submitted in the second...
Nasdaq GlobeNewswire
01/08/2023

ADC Therapeutics to Host Second Quarter 2023 Financial Results Conference Call…

To access the conference call, please registerhere. Registrants will receive the dial-in number and unique PIN. It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A live webcast of the call will be available under the “Events and Presentations” tab in the Investors section of the ADC Therapeutics website atir.adctherapeutics.com. The archived webcast will be available for 30 days following the call. About ADC Therapeutics ADC...
Nasdaq GlobeNewswire
01/08/2023

Evaxion announces financing commitments totaling up to USD 20 million with Negma…

Financing, available in multiple tranches over the next three years, could extend the Company's runway into Q4 2024Transaction will enable Evaxion to advance its next-generation cancer vaccine, EVX-03, towards a Phase 1 clinical trial Copenhagen, DENMARK, Aug.01, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today announced that it has...
Nasdaq GlobeNewswire
01/08/2023

ZENTIVA PRESENTS STRONG ESG PROGRESS IN SUSTAINABILITY REPORT 2022

Steffen Saltofte, CEO Zentiva:"Zentiva continues to make a significant contribution to public health inEurope. We are aware of our responsibility towards people, our partners and our planet. ESG (Environmental, Social, Governance) is helping us to navigate and fulfill our ambitions. Encouraging progress has been made in 2022 thanks to the engagement of our people and the cooperation and constructive dialogue with our partners and stakeholders." PEOPLE: We continued to...
PR Newswire
01/08/2023

Ajay Nair appointed President of TMG Search APAC

Ajay brings over two decades of deep industry expertise in MedTech and a proven track record of building high-performing teams across the U.S., Middle East, and Asia Pacific to The Mullings Group. Using his experience from roles across APAC, including key markets like China, Japan, Korea, India, and SEA, Ajay has successfully built his sales, marketing, and commercial leadership career with some of the top med device companies in the world. After spending the last three years working in V.C…
PR Newswire
01/08/2023

Invizius Receives MHRA Approval to Commence First-in-Human Clinical Study of…

Richard Boyd, Chief Executive Officer of Invizius, said: "The MHRA approval marks a significant milestone for Invizius as we progress into clinical development with our lead product H-Guard. We aim to improve quality of life for the millions of patients worldwide receiving haemodialysis and provide a life-changing solution to address complement-driven complications which results in a poor patient prognosis. We look forward to sharing results in due course." Richard Boyd, Chief…
PR Newswire
01/08/2023

RevitaLash® Cosmetics Announces New UK Distribution Partnership with Harpar…

"We are excited to join forces with Harpar Grace International," said Lori Jacobus, President and Global CMO of RevitaLash® Cosmetics. "Their dedication to serving their partners through a relationship-first approach with best-in-class business solutions aligns with our vision of providing the very best products and services to our customers. As a heritage professional channel brand, this collaboration allows us to remain true to our roots, and opens up additional avenues for…
PR Newswire
01/08/2023

Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A…

Press Release Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A (Hu14.18) from St. Jude Children's Research Hospital for the treatment of High-Risk NeuroblastomaRenaissance Pharma announces its first development program focused on Hu14.18, a humanised anti-GD2 monoclonal antibody, licensed from St. Jude Children's Research Hospital for the treatment of newly diagnosed high-risk neuroblastomaA novel key Phase II trial incorporated the addition of Hu14...
Nasdaq GlobeNewswire
01/08/2023

DAVINIA TAYLOR LAUNCHES NOOTROPICS & HALAL COLLAGEN

After turning her own life around, battling depression and addictions whilst shedding an incredible 3 stones through nutritional supplements, diet, and exercise, Davinia wants everyone to be able to achieve optimal health. After turning her own life around, battling depression and addictions whilst shedding an incredible 3 stones through nutritional supplements, diet, and exercise, Davinia wants everyone to be able to achieve optimal health. Today, the entrepreneur introduced two exciting...
PR Newswire
01/08/2023

ILIKOS Consulting Group and Simmunome Announce Strategic Partnership aimed at:

"Working closely with emerging biopharmaceutical companies has been a foundational objective since our inception. Adding Simmunome into our ecosystem of strategic partners enables us to extend their cutting-edge AI technology to our clients, helping them de-risk their development programs, make better informed decisions and gain more control over outcomes" – said Mr. Elias Sayias BSc. CCRA, Founder and CEO of ILIKOS. "Working closely with emerging biopharmaceutical companies has…
PR Newswire
01/08/2023

Kanazawa University research: Ion channel block unraveled

NavAb is a sodium channel cloned from a bacterium (Arcobacter butzleri) and has a well-known structure. Sumikama and Irie's colleagues performed experiments with NavAb and three mutants. The structures of the mutants were determined for environments with and without calcium. The scientists focused on the differences in electron densities for the different structures, as these provide insights into the locations of the calcium ions. They found that for the mutants displaying calcium blocking, one…
PR Newswire
01/08/2023

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin…

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studiesand Reports Second Quarterand Half-Year 2023 Financial Results Received feedback from U.S. Food and Drug Administration (FDA) on DBV's two supplemental safety studies in toddlers (ages 1 – 3 years) and children (ages 4 – 7 years) .The two Phase 3 pivotal safety studies will be named COMFORT Toddlers (1 – 3 years)...
Nasdaq GlobeNewswire
31/07/2023

REP Fitness Equipment Now Available for Pre-Order in the UK and Ireland

One of the USA's top gym equipment brands has joined forces with the UK's largest speciality fitness retailer. Starting this summer, Bodypower Sports Ltd. (trading as Fitness Superstore) will carry a large range of REP Fitness equipment. This expansion was in response to a growing demand overseas, after REP took the US by storm. It kicks off the launch of REP products throughout all of Europe, so more people can have access to REP's versatile, quality, innovative equipment. One of theUSA's...
PR Newswire
31/07/2023

FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology…

A second Numares assay is expected to gain FDA 510(k) clearance later this year, the AXINON® GFR(NMR) kidney function assay. A second Numares assay is expected to gain FDA 510(k) clearance later this year, theAXINON ® GFR(NMR) kidney function assay. Numares is a health care diagnostics company that develops improved diagnostic testing for conditions related to metabolic dysfunction, such as chronic kidney, liver and cardiac diseases. From a single blood sample, Numares quantifies...
PR Newswire
31/07/2023

Safe group announces suspension of financing agreement with Alpha Blue Ocean

Safe group announces suspension of financing agreement with Alpha Blue Ocean Éragny-sur-Oise, Fleurieux-sur-l'Arbresle , July31 st, 2023 at 6:00p .m. CET - Safe (FR001400F1V2 - ALSAF),a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for spinal fractures treated in emergency (the "Company") announces the suspension of its financing...
Nasdaq GlobeNewswire
31/07/2023

Insulin Delivery Devices Market worth $46.2 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107632092 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107632092 Browse in-depth TOC on "Insulin Delivery Devices Market" 151 - Tables 59 - Figures 229 - Pages Insulin Delivery Devices Market Scope: "Insulin pen delivery device segment to grow at the highest CAGR during the forecast period." Segments of the devices taken...
PR Newswire
31/07/2023

New Maxima International Sourcing Director – A. Voverė

As of August 1st, Agnė Voverė, member of the Board of MAXIMA GRUPĖ, UAB has been appointed as the CEO of MAXIMA International Sourcing, UAB. Recently, A. Voverė, who has been serving as Head of Baltic Region at "Maxima Grupė," has been assigned as the Director of "Maxima International Sourcing," a subsidiary of "Maxima LT." A. Voverė has been involved in various managerial positions within VP group companies since 2004. She has previously served as the Director at…
Nasdaq GlobeNewswire
31/07/2023

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to…

Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus' Established Commercial and Marketing Expertise in the Region ®(icosapent ethyl) across 10 countries, including nine in Southeast Asia (the Association of Southeast Asian Nations - ASEAN) and South Korea. VAZKEPA capsules have been approved and commercialized in a number of global markets, including the U.S. and European markets, as the first prescription treatment comprised solely of the active...
Nasdaq GlobeNewswire
31/07/2023

BioNTech Completes Acquisition of InstaDeep

Acquisition aims to strengthen BioNTech's pioneering position in the field of AI-powered drug discovery, design and developmentInstaDeep to operate as London based subsidiary of BioNTech and will be the centerpiece of its growing portfolio of initiatives around artificial intelligence and machine learningApproximately 290 highly skilled professionals and a global network of research partners in the fields of artificial intelligence, machine learning and data science based in the...
Nasdaq GlobeNewswire
31/07/2023
Altri  Comunicati